Loading...
OTCM
ONTTF
Market cap1.60bUSD
Dec 05, Last price  
1.72USD
1D
-3.29%
1Q
-20.00%
IPO
-79.92%
Name

Oxford Nanopore Technologies PLC

Chart & Performance

D1W1MN
OTCM:ONTTF chart
P/E
P/S
6.77
EPS
Div Yield, %
Shrs. gr., 5y
2.47%
Rev. gr., 5y
28.61%
Revenues
183m
+7.97%
149,49100746,0004,529,00013,787,00032,521,00052,061,000113,860,000133,661,000198,603,000169,668,000183,191,000
Net income
-146m
L-5.38%
-19,159,495-24,215,000-36,973,000-38,511,000-59,101,000-56,536,000-53,119,000-72,216,000-61,244,000-167,613,000-91,025,000-154,507,000-146,188,000
CFO
-110m
L-19.97%
-21,274,143-23,270,000-33,876,000-33,137,999-51,207,000-66,345,000-55,509,000-48,679,000-63,806,000-53,826,000-49,387,000-137,302,000-109,885,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Oxford Nanopore Technologies plc develops and commercializes a technology platform using nanopore-based sensing for the analysis of various types of molecules. The company offers MinION, a portable device for deoxyribonucleic acid and ribonucleic acid sequencing; GridION, a self-contained benchtop device for running and analyzing up to five MinION or Flongle flow cells; MinION Mk1C for basecalling and data analysis, touchscreen operation, and wireless connectivity; Flongle, an adapter for use in MinION or GridION devices to attach a Flongle flow cell; GridION Mk1, a benchtop nanopore sequencer; PromethION 2 Solo and PromethION 2, a low-cost access to high-yield PromethION sequencing; PromethION 24 and PromethION 48 benchtop nanopore-based sequencers for multiple users to deliver multi-sample and multi-experiment sequencing results; and VolTRAX, an USB-powered device, which automates laboratory processes upstream of nanopore sequencing. It also provides MinKNOW, a software that offers data acquisition, real-time analysis and feedback, local basecalling, and data streaming; Basecalling tools to determine the identity and order of bases on the DNA/RNA molecule; EPI2ME, a cloud-based data analysis platform for end-to-end analysis of nanopore data in real time; and EPI2ME Labs, a bioinformatics solution to assist users in developing their skills and confidence in the analysis of their nanopore-based sequencing data. In addition, the company is developing MinION Mk1D; Ubi; Plongle; and SmidgION products. It sells its products online. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies Limited in May 2008. Oxford Nanopore Technologies plc was incorporated in 2005 and is based in Oxford, the United Kingdom.
IPO date
Sep 30, 2021
Employees
1,049
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT